179 related articles for article (PubMed ID: 10385645)
21. High-Frequency Irreversible Electroporation for Treatment of Primary Liver Cancer: A Proof-of-Principle Study in Canine Hepatocellular Carcinoma.
Partridge BR; O'Brien TJ; Lorenzo MF; Coutermarsh-Ott SL; Barry SL; Stadler K; Muro N; Meyerhoeffer M; Allen IC; Davalos RV; Dervisis NG
J Vasc Interv Radiol; 2020 Mar; 31(3):482-491.e4. PubMed ID: 31956003
[TBL] [Abstract][Full Text] [Related]
22. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
Struyf S; Schutyser E; Gouwy M; Gijsbers K; Proost P; Benoit Y; Opdenakker G; Van Damme J; Laureys G
Am J Pathol; 2003 Nov; 163(5):2065-75. PubMed ID: 14578205
[TBL] [Abstract][Full Text] [Related]
23. Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta.
Zhang L; Derider M; McCornack MA; Jao SC; Isern N; Ness T; Moyer R; LiWang PJ
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13985-90. PubMed ID: 16963564
[TBL] [Abstract][Full Text] [Related]
24. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model.
Arenberg DA; Zlotnick A; Strom SR; Burdick MD; Strieter RM
Cancer Immunol Immunother; 2001 Jan; 49(11):587-92. PubMed ID: 11225989
[TBL] [Abstract][Full Text] [Related]
25. Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma.
Guo D; Qin L; Sun J; Li K; Zang C; Wang Q; Qiao W; Liu B; Zhao Y; Zhang Y
Technol Cancer Res Treat; 2023; 22():15330338231190644. PubMed ID: 37525880
[TBL] [Abstract][Full Text] [Related]
26. Physiology of chemokines in the cancer microenvironment.
Drouillard D; Craig BT; Dwinell MB
Am J Physiol Cell Physiol; 2023 Jan; 324(1):C167-C182. PubMed ID: 36317799
[TBL] [Abstract][Full Text] [Related]
27. Chemokines Associated with Pathologic Responses to Orthopedic Implant Debris.
Hallab NJ; Jacobs JJ
Front Endocrinol (Lausanne); 2017; 8():5. PubMed ID: 28154552
[TBL] [Abstract][Full Text] [Related]
28. CC chemokines Modulate Immune responses in Pulmonary Hypertension.
Yan Q; Liu S; Sun Y; Chen C; Yang Y; Yang S; Lin M; Long J; Lin Y; Liang J; Ai Q; Chen N
J Adv Res; 2023 Nov; ():. PubMed ID: 37926143
[TBL] [Abstract][Full Text] [Related]
29. Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling.
Vales S; Kryukova J; Chandra S; Smagurauskaite G; Payne M; Clark CJ; Hafner K; Mburu P; Denisov S; Davies G; Outeiral C; Deane CM; Morris GM; Bhattacharya S
Nat Commun; 2023 Sep; 14(1):5763. PubMed ID: 37717048
[TBL] [Abstract][Full Text] [Related]
30. Immunological assays for chemokine detection in in-vitro culture of CNS cells.
Mahajan SD; Schwartz SA; Nair MP
Biol Proced Online; 2003; 5():90-102. PubMed ID: 12734551
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST
Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734
[TBL] [Abstract][Full Text] [Related]
32. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.
Kubo T; Nishimura N; Kaji K; Tomooka F; Shibamoto A; Iwai S; Suzuki J; Kawaratani H; Namisaki T; Akahane T; Yoshiji H
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673992
[TBL] [Abstract][Full Text] [Related]
33. Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview.
Kayesh MEH; Kohara M; Tsukiyama-Kohara K
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298575
[TBL] [Abstract][Full Text] [Related]
34. HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.
Proulx J; Ghaly M; Park IW; Borgmann K
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453518
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver.
Ye X; Wang X; Yu W; Yang Q; Li Y; Jin Y; Su Y; Song J; Xu B; Sun H
Cancer Biol Med; 2021 Mar; 18(4):1092-108. PubMed ID: 33710817
[TBL] [Abstract][Full Text] [Related]
36. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver.
Wilkinson AL; Qurashi M; Shetty S
Front Physiol; 2020; 11():990. PubMed ID: 32982772
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma.
Kong XY; Vik ES; Nawaz MS; Berges N; Dahl TB; Vågbø C; Suganthan R; Segers F; Holm S; Quiles-Jiménez A; Gregersen I; Fladeby C; Aukrust P; Bjørås M; Klungland A; Halvorsen B; Alseth I
Nucleic Acids Res; 2020 May; 48(8):4463-4479. PubMed ID: 32083667
[TBL] [Abstract][Full Text] [Related]
38. Immune Cell Trafficking to the Liver.
Chaudhry S; Emond J; Griesemer A
Transplantation; 2019 Jul; 103(7):1323-1337. PubMed ID: 30817405
[TBL] [Abstract][Full Text] [Related]
39. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient.
Abutaleb A; Sherman KE
Hepatol Int; 2018 Nov; 12(6):500-509. PubMed ID: 30238230
[TBL] [Abstract][Full Text] [Related]
40. Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.
Nahon P; Sutton A; Ziol M; Zucman-Rossi J; Trinchet JC; Ganne-Carrié N
Hepat Oncol; 2015 Jan; 2(1):63-78. PubMed ID: 30190987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
